Related Experiment Videos
Continuous intravenous diltiazem infusion for short-term ventricular rate control in children
R H Pass1, L Liberman, M Al-Fayaddh
1Division of Pediatric Cardiology, Babies and Children's Hospital of New York, New York Presbyterian Medical Center, 10032-3784, USA. Pediheart@aol.com
The American Journal of Cardiology
|September 29, 2000
Insights
Intravenous diltiazem effectively controlled rapid heart rates in pediatric patients with atrial tachyarrhythmias. This medication provided safe and consistent temporary ventricular rate management for all participants.
Area of Science:
- Pediatric Cardiology
- Clinical Pharmacology
Background:
- Atrial tachyarrhythmias are common in pediatric patients.
- Rapid ventricular response can lead to hemodynamic instability.
Purpose of the Study:
- To evaluate the efficacy and safety of intravenous diltiazem for rate control in pediatric atrial tachyarrhythmias.
Main Methods:
- Intravenous diltiazem was administered to 10 pediatric patients.
- Patients had primary atrial tachyarrhythmias with rapid ventricular response.
Main Results:
- Rapid and consistent ventricular rate control was achieved in all patients.
- Diltiazem administration was safe for temporary rate management.
Conclusions:
- Intravenous diltiazem is an effective and safe option for temporary ventricular rate control in pediatric patients with atrial tachyarrhythmias.
Abstract:
Intravenous diltiazem was administered to 10 pediatric patients with primary atrial tachyarrhythmias with rapid ventricular response. Rapid, consistent, and safe temporary ventricular rate control was obtained in all patients given this medication.